Extension Study to Evaluate the Efficacy and Safety of investigational drug in Patients That Were Previously Enrolled Studies and have Eosinophilic Gastritis and/or Eosinophilic Duodenitis (formerly referred to as Eosinophilic Gastroenteritis)
Enrolling By Invitation
18 years - 99 years
All
Phase
3
1 Location
Brief description of study
This is an tension Study to Evaluate the Efficacy and Safety of investigational drug in Patients That Were Previously Enrolled Studies and have Eosinophilic Gastritis and/or Eosinophilic Duodenitis (formerly referred to as Eosinophilic Gastroenteritis). Only those who participated in previous study are being evaluated
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Eosinophilic Duodenitis, Eosinophilic Gastroenteritis
-
Age: 18 years - 99 years
-
Gender: All
Updated on
04 Aug 2024.
Study ID: 844069
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245
